COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN

TARGETED EXTRACELLULAR VESICLES FOR DELIVERY OF THERAPEUTICS

COMPOSITIONS AND METHODS OF USING PRKAG2-TARGETING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

COMPOSITIONS FOR AQUACULTURING

COMPOSITIONS AND METHODS TO TREAT CANCER

MEANS AND METHODS FOR REDUCING TUMORIGENICITY OF CANCER STEM CELLS

METHODS OF CANCER TREATMENT BY INHIBITION OF VASCULOGENESIS AND GLI1

siRNAs and shRNAs Targeting HIV and Combinations, Expression Cassettes, Cells and Use Thereof

MODIFICATION PATTERNS FOR SMALL INTERFERING RNA MOLECULES WITH HIGH STABILITY AND GENE SILENCING ACTIVITIES

DEAMINASE-BASED RNA SENSORS

ADVANCED RNA TARGETING (ARNATAR)

METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT

MODIFIED siRNA FOR SELECTIVELY INHIBITING EXPRESSION OF MUTANT FUS

METHODS AND COMPOSITIONS FOR CARDIAC MODELS

TARGETED COMPOSITIONS

CARRIER FOR PROMOTING FENTON REACTION AND PREPARATION PROCESS AND USES THEREOF

CONJUGATION OF LIPOPHILIC ALBUMIN-BINDING MOIETY TO RNA FOR IMPROVED CARRIER-FREE IN VIVO PHARMACOKINETICS AND GENE SILENCING

LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF

Method for Regulating and Controlling Heterologous Synthetic Flavonoid Compound and Use Thereof

COMPOSITIONS AND METHODS FOR INHIBITING KETOHEXOKINASE (KHK)

GENE THERAPY TARGETING THE NEONATAL FORM OF NAV1.5 FOR TREATING CANCER

Treatment Of Osteoarthritis With Cartilage Intermediate Layer Protein 2 (CILP2) Inhibitors

A GLUN2D INHIBITOR FOR USE IN THE TREATMENT OR RELAPSE PREVENTION OF A DEPRESSIVE EPISODE

BANCR Compositions and Methods for Treating Disease

COMPOSITIONS AND METHODS USEFUL IN PROMOTING MILK PRODUCTION

TREATMENT AND PREVENTION OF ALCOHOLIC LIVER DISEASE

Trialkyne Linking Agents and Methods of Use

Cationic Hyperbranched Starch-based Gene Carrier, Preparation Method and Application Thereof

Neurosome/Astrosome Compositions and Methods of Use

CANNULA SYSTEM AND USE THEREOF

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Treatment Of Acne Rosacea With Pancreatic Lipase-Related Protein 3 (PNLIPRP3) Inhibitors

COMPOSITIONS AND METHODS FOR SILENCING CARBONIC ANHYDRASE 2 EXPRESSION

HEPARIN SULFATE BIOSYNTHESIS PATHWAY ENZYME IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

TARGETING OF XKR8 IN THERAPIES

PHARMACEUTICAL COMPOSITION FOR SUPPRESSING INVASION OF CANCER, AND METHOD FOR SUPPRESSING INVASION OF CANCER

COMPOSITIONS AND METHODS FOR TREATING CANCER

TREATMENT OF BRAIN TUMORS BY TARGETING THE CHOLESTEROL PATHWAY IN ASTROCYES

COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND TARGETED SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS

m6A mRNA MODIFICATION IN CANCER TREATMENT

Method of Targeting Cells and Associated Compositions

HIF1A OR GLUT1 INHIBITION IN INFLAMMATORY SKIN DISEASES

Treatment Of Muscle Disorder With Folliculin Interacting Protein 1 (FNIP1) Inhibitors And/Or Folliculin (FLCN) Inhibitors

RNAi Agents for Inhibiting Expression of Inhibin Subunit Beta E (INHBE), Pharmaceutical Compositions Thereof, and Methods of Use

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES

RNAS FOR COMPLEMENT INHIBITION

OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION

AGENTS AND METHODS FOR PREVENTING OR INHIBITING ADAPTIVE IMMUNE RESPONSES ASSOCIATED WITH MULTIPLE SCLEROSIS

NOVEL CATIONIC LIPID COMPOUNDS

HYPERBRANCHED POLY(BETA-AMINO ESTER) FOR SIRNA DELIVERY AND GENE SILENCING

SMALL MOLECULE AND SIRNA INHIBITORS AGAINST LIPOCALIN-2

PREKALLIKREIN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

DETECTION OF GENETIC VARIANTS OF THE BETA-ADRENERGIC RECEPTOR PATHWAY FOR DETECTING AND TREATING RETINOPATHY OF PREMATURITY

DNA Amplification Method Using CARE Elements

Application of PRDX5 and GPX4 Genes in Preparation of Drugs for Castration-resistant Prostate Cancer

RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

AGT Inhibitor and Use Thereof

USE OF CCL7 ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DIABETIC KIDNEY DISEASE

Composition for Administration of Double-Stranded Oligonucleotide Structures Using Ultrasonic Nebulizer for Prevention or Treatment of Respiratory Viral Infection Including COVID-19, Pulmonary Fibrosis Caused by Viral Infection, or Respiratory Diseases

OLIGONUCLEOTIDES WITH INTERNUCLEOTIDE LINKAGE MODIFICATIONS FOR KIDNEY TARGETING

Advanced RNA targeting (ARNATAR) for angiotensinogen

METHODS AND MATERIALS FOR TREATING HEART ATTACK

COMPOSITIONS AND METHODS FOR TRANSFER USING CER1

AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENTS

MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF

ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

DEGRADABLE LIPID COMPOUND FOR ACTIVE MOLECULE DELIVERY AND NANOCOMPLEX THEREOF

IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

METHODS FOR THE TREATMENT OF NLRP3 RELATED DISORDERS

Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors

COMPOSITIONS FOR THE DELIVERY OF tRNA AS NANOPARTICLES AND METHODS OF USE THEREWITH

ENHANCED PRODUCTION OF SQUALENE IN PLANT SYSTEMS

METHODS AND COMPOSITIONS FOR TARGETED TRANS-SPLICING

CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B (CIDEB) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS OF tRNA SILENCING

TUNABLE REVERSIR TM COMPOUNDS

OPA1 ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES

BIOACTIVE CONJUGATES FOR OLIGONUCLEOTIDE DELIVERY

Chimeric Antigen Receptor-T Cells Targeting HIV-Infected Cells

NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF

COMPOSITIONS FOR RNA-PROTEIN TETHERING AND METHODS OF USING

METHODS AND COMPOSITIONS RELATED TO RNA-TARGETED RHO SMALL GTPase RND3/RhoE THERAPY

DIRECT PRODUCTION OF SIRNAS IN SACCHAROMYCES BOULARDII AND PACKAGING IN EXTRACELLULAR VESICLES (EVs) FOR TARGETED GENE SILENCING

MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF

iRNA Compositions and Methods for Silencing MYLIP

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

CELLS COMPRISING A SUPPRESSOR OF GENE EXPRESSION AND/OR A SYNTHETICPATHWAY ACTIVATOR AND/OR AN INDUCIBLE PAYLOAD

TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST

3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE (HMGCR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

PRODUCTS AND COMPOSITIONS

METHODS AND COMPOSITIONS FOR INHIBITING DETOXIFICATION RESPONSE

ATTENUATED ORTHOMYXOVIRUS-BASED VECTOR PLATFORM

TREATMENT OF FGG RELATED DISEASES AND DISORDERS

SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

GENETICALLY MODIFIED BIOPROSTHETIC HEART VALVE AND PRODUCTION METHOD THEREOF

EXTRACTION OF PLANT SOURCE "MEDICINAL SOUP" AND MANUAL PREPARATION OF "HERBAL MEDICINE" AND RELATED PRODUCTS

Subcutaneous Delivery of RNAi Agents for Inhibiting Expression of Receptor for Advanced Glycation End-products

RNAi Agents for Inhibiting Expression of PNPLA3, Pharmaceutical Compositions Thereof, and Methods of Use

Double Stranded Oligonucleotide For Modulating JAK1 Expression

OLIGONUCLEOTIDES FOR DGAT2, FASN, OPN, AND NOX4 MODULATIONS

CIRCULAR RNA DERIVED FROM RNA VIRUSES AND RELATED COMPOSITIONS AND METHODS

MODIFIED DOUBLE-STRANDED RNA AGENTS

NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY

STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B (CIDEB) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

GLYCAN CONJUGATE COMPOSITIONS AND METHODS

Novel Compositions for Conjugating Oligonucleotides and Carbohydrates

COMPOSITIONS AND METHODS OF USING PLN-TARGETING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES

COMPOSITIONS AND METHODS FOR MANAGEMENT OF WHITEFLY

USE OF MfERF026 GENE REGULATION IN GROWTH, DEVELOPMENT, AND STRESS TOLERANCE OF MEDICAGO SATIVA

LIPID-PEGYLATED COMPOUNDS, PREPARATIONS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS USING MODIFIED siRNA-GEM AGENTS

COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE UTILIZING A TRANSCRIPTIONAL MASTER REGULATOR OF THE RETROMER COMPLEX

STAGGERED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS

Compositions And Methods For Differentiation Of Human Pluripotent Stem Cells Into Desired Cell Types

MUSCLE TARGETING COMPLEXES FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF TMPRSS6 AND IRON CHELATORS

METHODS OF TARGETING RNF213 SIGNALING PATHWAY FOR TREATING DISEASES

HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS

NOVEL OXO-RNA COMPOSITIONS AND THE RELATED APPLICATIONS THEREOF

METHODS FOR THE TREATMENT OF HRD CANCER AND BRCA-ASSOCIATED CANCER

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TARGET CANCER INCLUDING BRCA-SPECIFIC siRNA AS ACTIVE INGREDIENT

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

IRNA COMPOSITIONS AND METHODS FOR SILENCING COMPLEMENT COMPONENT 3 (C3)

TARGETING LIGAND AND USE THEREOF

ENGINEERED CELL LINES FOR INCREASED PRODUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS (RAAV)

LIPID-BASED CONJUGATES FOR SYSTEMIC, CENTRAL NERVOUS SYSTEM, PERIPHERAL NERVOUS SYSTEM, AND OCULAR DELIVERY

PHARMACEUTICAL COMPOSITION FOR PROMOTING CANCER IMMUNOTHERAPY AND METHOD FOR PROMOTING CANCER IMMUNOTHERAPY

AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS

Methods for the Modification of Cells, Modified Cells and Uses Thereof

IRAP INHIBITORS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

NUCLEIC ACID INTERFERENCE PHARMACEUTICAL COMPOSITION, AND DRUG FOR TREATING COLORECTAL CANCER, GASTRIC CANCER, AND PROSTATE CANCER

COMPOSITIONS AND METHODS FOR ENHANCING GENE SILENCING ACTIVITY OF OLIGONUCLEOTIDE COMPOUNDS

APP iRNA Compositions and Methods of Use Thereof for Treating or Preventing Diseases Characterized by Enlarged Endosomes

HUNTINGTIN (HTT) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

PROBES FOR DEPLETING ABUNDANT SMALL NONCODING RNA

TARGETING APOE ENHANCES T-CELL KILLING IN CANCER IMMUNOTHERAPY

PEPTIDE-BINDING HYBRID LIPOSOME EXOSOME, PEPTIDE-BINDING EXOSOME, COMPOSITION CONTAINING SAME, AND METHOD OF FORMING SAME

COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY

METHODS AND COMPOSITIONS FOR TARGETING ALTERNATIVE METABOLISM ALONG WITH FLT3 INHIBITOR-MEDIATED ANTILEUKEMIC ACTIONS

PHOTO-CROSSLINKED BIOREDUCIBLE POLYMERIC NANOPARTICLES FOR ENHANCED RNA DELIVERY

METHODS TO IDENTIFY AND TREAT SUBJECTS HAVING CORTICOSTEROID-RESISTANT INFLAMMATORY DISEASES

GENETIC MODIFICATION OF MAMMALIAN CELLS TO CONFER RESISTANCE TO CSF1R ANTAGONISTS

COMPOSITIONS AND METHODS FOR TREATMENT OF MIC60 DEPLETED CANCERS AND METASTASIS

COMPOSITION FOR DIAGNOSIS, PREVENTION, OR TREATMENT OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATIVE DISEASE, USING MIRNA INHIBITOR

NUCLEIC ACIDS CONTAINING ABASIC NUCLEOSIDES

TREATMENT OF COMPLEMENT-MEDIATED DISORDERS

COMPOSITIONS AND METHODS FOR INHIBITING COMPLEMENT COMPONENT 3 EXPRESSION

Composition for inducing direct reprogramming comprising self-assembled RNA construct

Glioblastoma Multiforme Treatments

BLOCK COPOLYMERS AND USES THEREOF

Lipid nanoparticle compositions and uses thereof

POLY-GA PROTEINS IN ALZHEIMER’S DISEASE

ANTISENSE OLIGONUCLEOTIDES HAVING ONE OR MORE ABASIC UNITS

USE OF PI3KC2B INHIBITORS FOR THE PRESERVATION OF VASCULAR ENDOTHELIAL CELL BARRIER INTEGRITY

SIRNA STRUCTURES FOR HIGH ACTIVITY AND REDUCED OFF TARGET

OLIGONUCLEOTIDES FOR SARS-CoV-2 MODULATION

PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV

Means and Methods for Chronic Wound Healing

Compositions and Methods for Treating Cag Repeat Diseases

KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

MODIFIED SMALL INTERFERING RNA MOLECULES WITH REDUCED OFF-TARGET EFFECTS

Compositions For and Methods of Improving Viral Vectors

PEPTIDE HAVING INDEPENDENTLY STABILIZED HYDROPHOBIC ALPHA HELIX, PEPTIDE COMPLEX COMPRISING SAME AND USES THEREOF

TARGETING NANOPARTICLES FOR THERAPY

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

METHODS AND COMPOSITIONS FOR TARGETING SV2 PROTEINS FOR IMMUNE REGULATION

Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription

ORAL CODELIVERY OF 5-FLUOREURACIL AND Bcl2 siRNA TREATING STOMACH CANCER

AN ANTI-INFLAMMATORY COMPOSITION AND A METHOD OF OBTAINING THE SAME

OLIGONUCLEOTIDES FOR TISSUE SPECIFIC GENE EXPRESSION MODULATION

METHODS AND COMPOSITIONS FOR PROMOTING SURVIVAL & PROLIFERATION OF ENDOTHELIAL CELLS & STIMULATING ANGIOGENESIS

ORAL THERAPEUTIC VACCINE COMPOSITIONS, METHODS AND TREATMENT OF COVID

COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE

ORAL CODELIVERY OF NAVITOCLAX AND Bcl2 siRNA TREATING GASTIC CANCER

RNAi TARGETING PPP2R5D MISSENSE MUTATIONS FOR TREATMENT OF JORDAN’S SYNDROME

COMPOSITIONS AND METHODS FOR THE INHIBITION OF TUMOR METASTASIS AND HORIZONTAL GENE TRANSFER

iRNA Compositions and Methods for Targeting ANGPTL7

MODIFIED DOUBLE-STRANDED RNA AGENTS

LIPOPHILIC SIRNA CONJUGATES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES

RNAi TARGETING HNRNPH2 MISSENSE MUTATIONS FOR TREATMENT OF BAIN SYNDROME

RNAi TARGETING KIF1A MISSENSE MUTATIONS FOR TREATMENT OF KIF1A ASSOCIATED NEUROLOGICAL DISORDER

Atg8ylation coordinates stress granule formation and mTOR inactivation in response to lysosomal damage

FOXO1-TARGETED THERAPY FOR THE TREATMENT OF CANCER

CONDITION-ACTIVATABLE NUCLEIC ACID CONSTRUCTS AND THEIR USES FOR TREATING NEUROLOGICAL DISEASES

POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS

Muscle targeting complexes and uses thereof for treating dystrophinopathies

CELL-DERIVED NANOVESICLES FOR IN VIVO TRANSPORT AND DELIVERY OF THERAPEUTIC MATERIALS

COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

METHOD OF REGULATING PULMONARY ARTERY VASCULAR REMODELING

ADAMTS14 INHIBITION

FACTOR XII (F12) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

INHIBITION OF NEUROFIBRILLARY TANGLES USING OLIGONUCLEOTIDES AGAINST CIRCULAR RNAS FROM THE MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT) LOCUS

Compositions and methods for inhibiting LPA expression

ANGIOTENSINOGEN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

TUMOR DELIVERY OF DENDRITIC OLIGONUCLEOTIDES

IN VIVO DELIVERY OF OLIGONUCLEOTIDES

Compounds and Methods for Reducing ATXN2 Expression

AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

SGF29 AS A TARGET FOR HOX/MYC DRIVEN CANCERS

Muscle targeting complexes and uses thereof for treating dystrophinopathies

METHODS OF TREATING CANCER HAVING AN ACTIVE WNT/BETA-CATENIN PATHWAY

COMPOSITIONS AND METHODS FOR GENERATING SYNTHETIC LETHALITY IN TUMORS

CATIONIC POLYMERS

METHODS FOR ALTERING GENE EXPRESSION FOR GENETIC DISORDERS

TREATMENT OF MST1R RELATED DISEASES AND DISORDERS

Treatment of MST1 related diseases and disorders

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of Use

LIGAND CONJUGATES FOR DELIVERY OF THERAPEUTICALLY ACTIVE AGENTS

Site-Specific Crosslinking of Antibodies

NKD2 AS TARGET FOR TREATING RENAL FIBROSIS

IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY

Gene-regulating compositions and methods for improved immunotherapy

INHIBITOR OLIGONUCLEOTIDES AND METHODS OF USE THEREOF

COMPOSITIONS FOR AND METHODS OF TREATING AND/OR PREVENTING GLUTARIC ACIDURIA TYPE-1

HSD17B13-RELATED DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO

TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHY

Method For Promoting Differentiation Of Pluripotent Stem Cells By Reducing Undifferentiated State Thereof

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF GENES ASSOCIATED WITH MUSCLE HEALTH

RNA binding and stabilising cationic liposome, its application and method of loading the liposome with emetine

LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF

PLANT VECTORS, COMPOSITIONS AND USES RELATING THERETO

COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF

NUCLEIC ACID TARGETING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN 9 AND USES THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) PROTEIN

Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors

ENGINEERED PRODUCER CELL LINES AND METHODS OF MAKING AND USING THE SAME

TKTL1 INHIBITORS FOR ANTIVIRAL THERAPY

INCLUSION BODY MEDIATED METHOD FOR DOUBLE-STRANDED RNA PRODUCING

IL-34 ANTISENSE AGENTS AND METHODS OF USING SAME

NCOVSIRNA DRUG FOR TARGETED DELIVERY SHRNA by RBD, SYNTHESIS METHOD, AND APPLICATION THEREOF

NOVEL COMPOUND AND APPLICATION THEREOF

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING CD300C EXPRESSION INHIBITOR OR ACTIVITY INHIBITOR

HUNTINGTIN (HTT) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Targeting GPR65 for the Treatment of Cancer in Overweight and Obese Individuals

ACTIVATION OF SURVIVIN-SPECIFIC IMMUNE RESPONSES USING DENDRITIC CELL DERIVED EXOSOMES

METHODS FOR THE TREATMENT OF OCULAR ROSACEA

SELECTIVE INHIBITORS OF ROCK2 FOR THE TREATMENT OF MUSCULAR DYSTROPHY

SELF-INACTIVATING VECTORS FOR GENE EDITING

SYNTHETIC RNAS AND USES THEREOF

RENAL INJURY BIOMARKERS AS BIOMARKERS FOR ACUTE HEPATIC PORPHYRIA (AHP)

LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

CANCER TREATMENT USING siRNA TO MODULATE EXPRESSION OF PRDM2/RIZ PROTEIN

DENDRITIC CONJUGATES FOR THE BRAIN DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES

TREATMENT OF FIBROSIS

MULTIGENE CONSTRUCTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER COMPLEMENT DYSREGULATION-RELATED CONDITIONS

EXTRAHEPATIC DELIVERY

GASDERMIN-D INHIBITORS AND USES THEREOF FOR TREATING PULMONARY VASO-OCCLUSION

High Efficiency Beef Cattle Having Modified ACTN3 Genes

HAIRPIN NUCLEIC ACID COMPOSITION

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

SNRNA TARGETING USH2A PRE-MRNA AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR SIRNA TREATMENT OF MUSCULAR DYSTROPHY

DOUBLE STRANDED NUCLEIC ACID COMPOUNDS INHIBITING ZPI

CONTROL OF INSECT INFESTATION

THREE-DIMENSIONAL DIRECT NEURONAL REPROGRAMMING TO MODEL ALZHEIMER'S DISEASE IN HUMAN NEURONS

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

PHARMACEUTICAL COMPOSITIONS TARGETING IMMUNE-MEDIATED PROCESSES IN NEURODEGENERATIVE DISEASE

INHIBITION OF KYNURENINE SYNTHESIS AND/OR SIGNALING TO TREAT LEUKEMIA AND MYELODYSPLASIA

METHODS FOR TREATMENT OF NEURON DEGENERATION

METHODS FOR MODULATING THE REGENERATIVE PHENOTYPE IN MAMMALIAN CELLS

DENDRITIC CONJUGATES FOR THE SKIN DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES

PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TREATMENT FOR TYROSINE DEGRADATION-ASSOCIATED DISORDERS

Products and Methods for Treatment of Amyotrophic Lateral Sclerosis

METHODS AND COMPOSITIONS FOR TREATING SUBJECTS HAVING OR AT RISK OF DEVELOPING A NON-PRIMARY HYPEROXALURIA DISEASE OR DISORDER

DUAL FUNCTION HYBRID NANOPARTICLES AND METHODS OF USING THE SAME TO TREAT DISEASES AND DISORDERS

COMPOSITIONS AND METHODS FOR INHIBITING LPA EXPRESSION

SPINK1 AS A TARGET FOR THERAPEUTIC INTERVENTION IN LUNG DISEASES

METHODS FOR TREATING SICKLE CELL DISEASE OR BETA THALASSEMIA USING COMPLEMENT ALTERNATIVE PATHWAY INHIBITORS

A SHORTENED P63-PROTEIN DOMAIN TO ENHANCE HUMAN CARDIAC REPROGRAMMING

TREATMENT OF CANCERS OR NEOPLASMS BY INHIBITING KIF15

CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF

INHIBITORS OF EXPRESSION AND/OR FUNCTION

USE OF OLIGONUCLEOTIDES FOR INDIVIDUALS WITH RENAL IMPAIRMENT

METHODS OF CONTROLLING RNA BINDING PROTEIN ACTIVITY

COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF TMIGD2

COMPOUNDS AND METHODS FOR REDUCING DUX4 EXPRESSION

2'-MODIFIED NUCLEOSIDE BASED OLIGONUCLEOTIDE PRODRUGS

PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS

A NON-CANONICAL SIGNALING ACTIVITY OF CGAMP TRIGGERS DNA DAMAGE RESPONSE SIGNALING

ANTISENSE OLIGONUCLEOTIDES TARGETING UNC13A

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL

GALNAC-MONOMERS AND GALNAC-NUCLEIC ACID CONJUGATES

COMPOSITIONS COMPRISING DOPED SILICON PARTICLES, AND RELATED METHODS

NOVEL THERAPEUTIC DELIVERY MOIETIES AND USES THEREOF

MODULATORS OF ENaC EXPRESSION

MODIFIED OLIGONUCLEOTIDES TARGETING SNPs

METHODS FOR REACTIVATING GENES ON THE INACTIVE X CHROMOSOME

LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF SERUM AMYLOID A GENE

NUCLEIC ACID CONSTRUCT ENABLING EXPRESSION AND INHIBITION OF GENE SIMULTANEOUSLY